Stéphanie Gofflot

2.7k citations

20 papers · 511 indexed · h-index 11

Co-authors: Philippe Delvenne Ernst Heinen Vincent Castronovo Brunella Costanza Willy Zorzi Akeila Bellahcène Douglas Vernimmen Madeleine Grooteclaes
Topics: SARS-CoV-2 and COVID-19 Research (3 papers)Prion Diseases and Protein Misfolding (3 papers)COVID-19 Clinical Research Studies (3 papers)
Cited by: Genetics Oncology Cancer Research
Journals: PLoS ONE Oncogene Scientific Reports
Partner nations: Belgium France Italy

In The Last Decade

Stéphanie Gofflot

20 papers receiving 504 citations

Peers

Countries citing papers authored by Stéphanie Gofflot

Since Specialization

Citations

This map shows the geographic impact of Stéphanie Gofflot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphanie Gofflot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphanie Gofflot more than expected).

Fields of papers citing papers by Stéphanie Gofflot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphanie Gofflot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphanie Gofflot. The network helps show where Stéphanie Gofflot may publish in the future.

Co-authorship network of co-authors of Stéphanie Gofflot

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphanie Gofflot. A scholar is included among the top collaborators of Stéphanie Gofflot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphanie Gofflot. Stéphanie Gofflot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting ferroptosis resistance resensitizes metastatic HR ⁺ HER2 ⁻ breast cancer cells to palbociclib‐hormone therapy 2025 ·Cancer Communications ·Charles Pottier,(unknown),(unknown),(unknown),Dominique Baiwir,Gabriel Mazzucchelli,(unknown),(unknown),Claire Josse,Andrée Rorive,Stéphanie Gofflot,Ahmed Dahmani,Ludivine Morisset,Joëlle Collignon,Philippe Delvenne,Elisabetta Marangoni,Agnès Noël,Guy Jérusalem,Nor Eddine Sounni	1
2	Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism 2023 ·Therapeutic Advances in Hematology ·(unknown),(unknown),Alizée Lebeau,(unknown),Marianne Fillet,(unknown),(unknown),Gaël Cobraiville,(unknown),Stéphanie Gofflot,Yves Béguin,Gaëlle Vertenoeil	2
3	Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV 2023 ·Viruses ·(unknown),(unknown),(unknown),Nathalie Maes,(unknown),(unknown),(unknown),(unknown),Stéphanie Gofflot,(unknown),Marie‐Pierre Hayette,Pieter Vermeersch,Laurence Lutteri,Céline Grégoire,Yves Béguin,Souad Rahmouni,Michel Moutschen,Daniël Desmecht,Gilles Darcis	1
4	Genetic diversity of Echinococcus multilocularis specimens isolated from Belgian patients with alveolar echinococcosis using EmsB microsatellites analysis 2023 ·Infection Genetics and Evolution ·Rosalie Sacheli,Jenny Knapp,(unknown),(unknown),Philippe Léonard,Jean‐Baptiste Giot,(unknown),Noëlla Blétard,Stéphanie Gofflot,Marie‐Cécile Nollevaux,Paul Meunier,Pierre Lovinfosse,(unknown),Carine Truyens,Laurence Millon,Olivier Detry,Marie‐Pierre Hayette	2
5	The PTX3/TLR4 autocrine loop as a novel therapeutic target in triple negative breast cancer 2023 ·Experimental Hematology and Oncology ·Arianna Giacomini,(unknown),Elisabetta Grillo,Sara Rezzola,Gaia C. Ghedini,(unknown),Eleonora Foglio,Federica Maccarinelli,(unknown),(unknown),Angela Chambery,Mariangela Valletta,Laura Melocchi,Stéphanie Gofflot,Barbara Chiavarina,Andrei Turtoï,Marco Presta,Roberto Ronca	8
6	Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers 2022 ·Scientific Reports ·Céline Grégoire,Pascale Huynen,Stéphanie Gofflot,Laurence Seidel,Nathalie Maes,(unknown),(unknown),Michel Moutschen,Marie‐Pierre Hayette,Philippe Kolh,Pierrette Melin,Y Beguin	2
7	Increased KL-6 levels in moderate to severe COVID-19 infection 2022 ·PLoS ONE ·(unknown),Monique Henket,(unknown),Stéphanie Gofflot,Marie Thys,(unknown),Anna Julie Peired,Ingrid Struman,Anne‐Françoise Rousseau,Benoît Misset,Gilles Darcis,Michel Moutschen,Renaud Louis,Makon‐Sébastien Njock,Étienne Cavalier,Julien Guiot	4
8	Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers 2022 ·Scientific Reports ·Pascale Huynen,Céline Grégoire,Stéphanie Gofflot,Laurence Seidel,Nathalie Maes,(unknown),(unknown),Michel Moutschen,Marie‐Pierre Hayette,Philippe Kolh,Pierrette Melin,Y Beguin	4
9	The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities 2020 ·Theranostics ·Mélissa Alame,Emmanuel Cornillot,Valère Cacheux,(unknown),(unknown),(unknown),Stéphanie Gofflot,Philippe Delvenne,Evgenia Turtoi,Simon Cabello‐Aguilar,Masahiko Nishiyama,Andrei Turtoï,Valérie Costes‐Martineau,Jacques Colinge	28
10	Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness 2018 ·Oncogene ·Gilles Rademaker,(unknown),Laura Brohée,Marie‐Julie Nokin,Pierre Lovinfosse,Florence Durieux,Stéphanie Gofflot,Justine Bellier,Brunella Costanza,Michaël Herfs,(unknown),Lucien Bettendorff,Christophe Deroanne,Marc Thiry,Philippe Delvenne,Roland Hustinx,Akeila Bellahcène,Vincent Castronovo,Olivier Peulen	49
11	MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib 2017 ·British Journal of Cancer ·(unknown),Pierre Foidart,Joan Somja,(unknown),(unknown),(unknown),Hélène Schroeder,Stéphanie Gofflot,(unknown),Joëlle Collignon,Philippe Delvenne,Nor Eddine Sounni,Guy Jérusalem,Agnès Noël	16
12	A specific immune and lymphatic profile characterizes the pre-metastatic state of the sentinel lymph node in patients with early cervical cancer 2017 ·OncoImmunology ·Cédric Balsat,Silvia Blacher,Michaël Herfs,Maureen Van de Velde,Nicolas Signolle,Philippe Sauthier,Charles Pottier,Stéphanie Gofflot,(unknown),Philippe Delvenne,Frédéric Goffin,Agnès Noël,Frédéric Kridelka	27
13	Surveillance of effects of HPV vaccination in Belgium 2016 ·Cancer Epidemiology ·Marc Arbyn,Davy Vanden Broeck,Ina Benoy,Johannes Bogers,Christophe Depuydt,Marleen Praet,P. De Sutter,Anne Hoorens,Esther Hauben,Willy Poppe,Marc Van Ranst,Philippe Delvenne,Stéphanie Gofflot,Michel Pétein,(unknown),(unknown),(unknown),Pierre Van Damme,Marleen Temmerman,Steven Weyers	19
14	Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer 2015 ·PLoS Medicine ·Pamela Maris,Arnaud Blomme,(unknown),Brunella Costanza,Akeila Bellahcène,Elettra Bianchi,Stéphanie Gofflot,Pierre Drion,(unknown),Emmanuel Di Valentin,P. Cusumano,Sylvie Maweja,Guy Jérusalem,Philippe Delvenne,(unknown),Vincent Castronovo,Andrei Turtoï	102
15	Decontamination of Prions by the Flowing Afterglow of a Reduced‐pressure N₂O₂ Cold‐plasma 2012 ·Plasma Processes and Polymers ·Benaïssa Elmoualij,Olivier Thellin,Stéphanie Gofflot,Ernst Heinen,(unknown),Jacynthe Séguin,Michel Moisan,(unknown),Jean Barbeau,Willy Zorzi	26
16	Characterization of an antibody panel for immunohistochemical analysis of canine muscle cells 2008 ·Veterinary Immunology and Immunopathology ·Stéphanie Gofflot,Philippe Kischel,Caroline Thielen,(unknown),Jacques Boniver,Laurence de Leval	5
17	Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium 2006 ·American Journal of Physiology-Heart and Circulatory Physiology ·Jozef Bartunek,J Croissant,William Wijns,Stéphanie Gofflot,Aurore de Lavareille,Marc Vanderheyden,Yulia Kaluzhny,(unknown),(unknown),Martin Pěnička,Myrielle Mathieu,Christian Homsy,Bernard De Bruyne,Kathleen Mc Entee,(unknown),Guy R. Heyndrickx	110
18	Immunoquantitative PCR for Prion Protein Detection in Sporadic Creutzfeldt–Jakob Disease 2005 ·Clinical Chemistry ·Stéphanie Gofflot,Manuel Deprez,Benaı̈ssa El Moualij,Awad A. Osman,(unknown),(unknown),Ernst Heinen,Willy Zorzi	29
19	Immuno‐Quantitative Polymerase Chain Reaction for Detection and Quantitation of Prion Protein 2004 ·Journal of Immunoassay and Immunochemistry ·Stéphanie Gofflot,Benaı̈ssa El Moualij,(unknown),(unknown),S. Roels,(unknown),Jacques Grassi,E. Vanopdenbosch,Ernst Heinen,Willy Zorzi	27
20	Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression 2003 ·Biochemical Journal ·Douglas Vernimmen,Dominique Begon,(unknown),Stéphanie Gofflot,Madeleine Grooteclaes,Rosita Winkler	49

About Stéphanie Gofflot

Stéphanie Gofflot is a scholar working on Dermatology, Oncology and Infectious Diseases, having authored 20 papers that have together received 511 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (3 papers), Prion Diseases and Protein Misfolding (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Genetics (85 citations), Oncology (159 citations) and Cancer Research (65 citations). Stéphanie Gofflot has collaborated with scholars based in Belgium, France and Italy. Frequent co-authors include Philippe Delvenne, Ernst Heinen, Vincent Castronovo, Brunella Costanza, Willy Zorzi, Akeila Bellahcène, Douglas Vernimmen, Madeleine Grooteclaes, Rosita Winkler and Dominique Begon. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact